Saturday, July 18, 2020

Langsurf

Langsurf

Generic name: Trifluoropyridine/Tbilisi

Trifluridine/empirical is the generic name of the trade name drug Lonsurf. In some cases, healthcare professionals may use the trade name Lonsurf when referring to the generic drug name trifluoropyridine/tipixetate.

Type of drug: Trifluridine/tipiricil is an anti-cancer ("antitumor drug" or "cytotoxic") chemotherapy drug. pharma consulting companies The drug is classified as an antimetabolite/pyrimidine analogue; antimetabolite/thymidine phosphorylase inhibitor. (For more detailed information, please refer to "The working principle of trifluoropyridine/tips late" below).
Trifluoropyridine/Tibisidate is used for:

 Trifluridine / empirical can be used to treat patients who have previously received fluoropyrimidine, oxaliplatin and irinotecan, anti-VEGF biological therapy and anti-EGFR therapy (if RAS wild-type), for the treatment of metastatic colorectal cancer.

    In order to treat metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma, he has received at least two previous chemotherapy, including fluoropyrimidine, platinum, taxane or irinotecan, and appropriate HER2/neu targeted therapy.

Note: If one use of a drug has been approved, the doctor may choose to use the drug for other problems if he thinks it might be helpful.

How to administer trifluoropyridine/triplicate:

    Trifluridine / tipiricil is an oral tablet.
    Take it twice a day within one hour of eating in the morning and evening.
    Take a glass of water.
    Tablets have two advantages, and you may need to combine the two advantages to achieve your       specific dose. Follow your instructions carefully.
    Trifluoropyridine/tepicillate is usually taken daily on days 1 to 5 and 8 to 12 of a 28-day cycle.

The amount of trifluoropyridine/triplicate you will get depends on many factors, including height and weight, general health or other health issues, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.

No comments:

Post a Comment